You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AZD1402

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subjects (Indication: Asthma) Trial in Harrow (Elarekibep, Placebo)

Not yet recruiting
  • Healthy Subjects (Indication: Asthma)
  • Harrow, United Kingdom
    Research Site
Mar 20, 2023

Asthma Trial in Worldwide (AZD1402, Placebo, Short acting beta agonist (SABA) (rescue medication))

Recruiting
  • Asthma
  • AZD1402
  • +3 more
  • Herston, Australia
  • +46 more
May 16, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +2 more
  • Los Angeles, California
  • +17 more
Jan 27, 2023

Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)

Active, not recruiting
  • Recurrent Glioblastoma
  • Bevacizumab
  • +3 more
  • La Jolla, California
  • +26 more
Jun 28, 2022

Asthma Trial in Harrow (AZD1402)

Completed
  • Asthma
  • AZD1402
  • Harrow, United Kingdom
    Research Site
Jun 20, 2019

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung

Recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +6 more
  • Anchorage, Alaska
  • +518 more
Aug 23, 2022

Diabetic Peripheral Neuropathy Trial (FE-SYHA1402 100mg, SYHA1402-25mg, Placebo-25mg)

Unknown status
  • Diabetic Peripheral Neuropathy
  • FE-SYHA1402 100mg
  • +6 more
  • (no location specified)
Jun 28, 2020

Safety, Pharmacokinetics, Pharmacodynamics, Food Effect Trial in Harrow (AZD7986, oral solution, 1 to 50 mg/mL, Placebo, oral

Completed
Has Results
  • Safety, Pharmacokinetics, Pharmacodynamics, Food Effect
  • AZD7986, oral solution, 1 to 50 mg/mL
  • Placebo, oral solution
  • Harrow, United Kingdom
    Research Site
Dec 10, 2018